Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-tumor antibody compositions and methods of use

Anti-tumor antibody compositions and methods of use

US Patent 7435416 · Granted Oct 14, 2008

Estimated economic value: $158,830,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Antibodies against TIM3 and uses thereof2025
Antibodies against TIM3 and uses thereof2024
Antibodies to TIGIT2024
Anti-CD40 antibodies and uses thereof2024
Antibodies against TIM3 and uses thereof2023
Anti-PD-L1 antibodies and diagnostic uses thereof2022
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2022
Anti-CD40 antibodies and uses thereof2022
Biomarkers and methods of treating PD-1 and PD-L1 related conditions2022
Antibodies to TIGIT2021
Nucleic acids encoding an anti-CD40 antibody2020